Rinvoq and Sipuleucel-t Intravenous

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer information for this interaction is not currently available.MONITOR: Neither the leukapheresis procedure nor sipuleucel-T has not been studied for use in combination with chemotherapy or immunosuppressive agents (e.g., systemic corticosteroids). Since sipuleucel-T is designed to stimulate the immune system, concurrent use of myelo- or immunosuppressive agents may alter the efficacy and/or safety of sipuleucel-T. MANAGEMENT: Patients should be carefully evaluated to determine whether it is medically appropriate to reduce or discontinue chemotherapy or immunosuppressive agents prior to treatment with sipuleucel-T. References "Product Information. Provenge (sipuleucel-T)." Dendreon Corporation, Seattle, WA.

MONITOR: Neither the leukapheresis procedure nor sipuleucel-T has not been studied for use in combination with chemotherapy or immunosuppressive agents (e.g., systemic corticosteroids). Since sipuleucel-T is designed to stimulate the immune system, concurrent use of myelo- or immunosuppressive agents may alter the efficacy and/or safety of sipuleucel-T.

MANAGEMENT: Patients should be carefully evaluated to determine whether it is medically appropriate to reduce or discontinue chemotherapy or immunosuppressive agents prior to treatment with sipuleucel-T.

Rinvoq

Generic Name: upadacitinib

Brand name: Rinvoq

Synonyms: n.a.

What is Rinvoq?

Sipuleucel-t Intravenous

Generic Name: sipuleucel-T

Brand name: Provenge

Synonyms: Sipuleucel-T

What is Sipuleucel-t Intravenous?